Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Effect of Delta-9-tetrahydrocannabinol on mouse resistance to systemic Candida albicans infection.

Blumstein GW, Parsa A, Park AK, McDowell BL, Arroyo-Mendoza M, Girguis M, Adler-Moore JP, Olson J, Buckley NE.

PLoS One. 2014 Jul 24;9(7):e103288. doi: 10.1371/journal.pone.0103288. eCollection 2014.

2.

Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Brieland J, Essig D, Jackson C, Frank D, Loebenberg D, Menzel F, Arnold B, DiDomenico B, Hare R.

Infect Immun. 2001 Aug;69(8):5046-55.

3.

Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaques.

Chandra LC, Kumar V, Torben W, Vande Stouwe C, Winsauer P, Amedee A, Molina PE, Mohan M.

J Virol. 2015 Jan 15;89(2):1168-81. doi: 10.1128/JVI.01754-14. Epub 2014 Nov 5.

4.

Paeoniflorin augments systemic Candida albicans infection through inhibiting Th1 and Th17 cell expression in a mouse model.

Kong X, Leng D, Liang G, Zheng H, Wang Q, Shen Y, Lu G, Zhang H, Shi D, Liu W.

Int Immunopharmacol. 2018 Jul;60:76-83. doi: 10.1016/j.intimp.2018.03.001. Epub 2018 Apr 26.

PMID:
29705532
5.

Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines.

Villamón E, Gozalbo D, Roig P, Murciano C, O'Connor JE, Fradelizi D, Gil ML.

Eur Cytokine Netw. 2004 Jul-Sep;15(3):263-71.

6.

Psychoactive cannabinoids increase mortality and alter acute phase cytokine responses in mice sublethally infected with Legionella pneumophila.

Smith MS, Yamamoto Y, Newton C, Friedman H, Klein T.

Proc Soc Exp Biol Med. 1997 Jan;214(1):69-75.

PMID:
9012363
7.

A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.

Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T.

Int J Neuropsychopharmacol. 2010 Aug;13(7):861-76. doi: 10.1017/S1461145709990605. Epub 2009 Sep 29.

PMID:
19785914
8.

Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.

Li Wq, Hu Xc, Zhang X, Ge Y, Zhao S, Hu Y, Ashman RB.

Vaccine. 2011 Jul 26;29(33):5526-33. doi: 10.1016/j.vaccine.2011.05.030. Epub 2011 Jun 7.

PMID:
21645574
9.

Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein.

Londono LP, Jones HB, Vie AT, McPheat WL, Booth G, Gao XM, Dougan G.

FEMS Immunol Med Microbiol. 2000 Feb;27(2):117-25.

10.

Gastrointestinal colonisation and systemic spread of Candida albicans in mice treated with antibiotics and prednisolone.

Kobayashi-Sakamoto M, Tamai R, Isogai E, Kiyoura Y.

Microb Pathog. 2018 Apr;117:191-199. doi: 10.1016/j.micpath.2018.02.043. Epub 2018 Feb 22.

PMID:
29477742
11.

ISG15 in Host Defense Against Candida albicans Infection in a Mouse Model of Fungal Keratitis.

Dong C, Gao N, Ross BX, Yu FX.

Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):2948-2958. doi: 10.1167/iovs.17-21476.

12.
13.

Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose Delta-9-tetrahydrocannabinol (THC).

Mayer TA, Matar MA, Kaplan Z, Zohar J, Cohen H.

Pharmacol Biochem Behav. 2014 Jul;122:307-18. doi: 10.1016/j.pbb.2014.04.014. Epub 2014 May 6.

PMID:
24814135
14.

Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells.

Tarumoto N, Kinjo Y, Kitano N, Sasai D, Ueno K, Okawara A, Izawa Y, Shinozaki M, Watarai H, Taniguchi M, Takeyama H, Maesaki S, Shibuya K, Miyazaki Y.

J Infect Dis. 2014 Mar 1;209(5):799-810. doi: 10.1093/infdis/jit534. Epub 2013 Oct 4.

15.

Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.

Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE.

J Leukoc Biol. 2008 Dec;84(6):1574-84. doi: 10.1189/jlb.0508282. Epub 2008 Sep 12.

16.

Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.

Vonk AG, Netea MG, van Krieken JH, Iwakura Y, van der Meer JW, Kullberg BJ.

J Infect Dis. 2006 May 15;193(10):1419-26. Epub 2006 Apr 4.

PMID:
16619190
17.

Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model.

Navarathna DH, Nickerson KW, Duhamel GE, Jerrels TR, Petro TM.

Infect Immun. 2007 Aug;75(8):4006-11. Epub 2007 May 21.

18.

Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.

Mullick A, Elias M, Picard S, Bourget L, Jovcevski O, Gauthier S, Tuite A, Harakidas P, Bihun C, Massie B, Gros P.

Infect Immun. 2004 Oct;72(10):5868-76.

19.

Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections.

Yordanov M, Dimitrova P, Patkar S, Falcocchio S, Xoxi E, Saso L, Ivanovska N.

J Med Microbiol. 2005 Jul;54(Pt 7):647-53.

PMID:
15947429
20.

Acute susceptibility of aged mice to infection with Candida albicans.

Ashman RB, Papadimitriou JM, Fulurija A.

J Med Microbiol. 1999 Dec;48(12):1095-102.

PMID:
10591163

Supplemental Content

Support Center